Team & Expertises

Over years, CarthaGenetics® has built a highly skilled network of regional coordinators and local experts. With close to twenty professionals having a life sciences background, our team is specialized in innovative therapies, patient identification, drug development program management, medical affairs, in-country legislation, liaison with physicians, and more generally market access best practice. Applying a high level of ethics, we can help you step into the most complex markets in Europe, including Turkey, as well as North Africa. Meet with the experts:



Philippe Carteron de Balmon


General Manager And Founder

Philippe founded CarthaGenetics in 2004 with the vision that an international expert team could leverage better synergies between biotech companies, physicians and local authorities in order to speed drug development and get more patients treated in Europe.
Prior to this, Philippe worked for over two decades as country manager at key biotechnology companies involved in the Orphan Drug (OD) market. Philippe was instrumental in “pre-launching” and “launching” some of the most visible OD brands in EMEA, among them: Ceredase®, Cerezyme®, Replagal®, Naglazyme®, Soliris®, Vyndaqel®, Glybera®, Juxtapid®/Lojuxta™, Gattex®/Revestive®, Metopitone®, Translarna™.
As General Manager, Philippe has a passion for medical affairs and key negotiations with government bodies, including Health and Social ministers, regulatory agencies and patient associations, and has been participating in policy development and OD implementation, notably in Turkey. Philippe has a Master in Biology, in Pharmaceutical Marketing (Institut Supérieur de Gestion, Paris 16e), and holds an Executive Master in International Negotiation and Policy Making (The Graduate Institute, IHEID, Geneva).
Philippe is based in Geneva, Switzerland.

Sabri Hammar



Sabri holds a Master in Accounting from HEC Carthage, and is graduated from ENA (High National School of Administration, Tunis)
Cofounder of CarthaGenetics in 2004 with Philippe Carteron de Balmont,Sabri helped to set up the corporate infrastructure and to develop the Tunisian team. Sabri is based in Carthage, Tunisia.

Sabri Hammar


Chief Marketing Officer

Pascal is Chief Marketing Officer at CarthaGenetics®, with responsibility for marketing programs, brand management, communications, business development and corporate sponsorships. Prior to joining the team, he worked in strategic business development and marketing at several companies in the high tech industry, as well as a go-to-market consultant. Notable is his fifteen years as Marketing and Communications Director, EMEA, for global semiconductor leader  Analog Devices, where he directed major initiatives to develop the brand in emerging markets, including healthcare applications (patient monitoring, medical equipment, ultrasound).
Pascal holds a Master’s Degree in Business Administration and Innovation Marketing from   the  Skema Group Graduate School of Management, Sophia Antipolis, and is a member of the EACD Brussels (European Association of Communication Directors).
Pascal is based in Paris, France.


Sabri Hammar


Administrative And Finance Director

Salma holds a Master in Finance from Sfax University. After an experience in audit, she joined CarthaGenetics in 2009, and is responsible for our finance team.
Salma is based in Carthage, Tunisia.

Sabri Hammar


Finance Assistant

Mohamed Walid holds a Master’s degree in Entrepreneurship and a BA in Finance from IHEC-Carthage.  With strong and diversified background, he worked for companies as various as various as Tunisian National Oil firm, MARETAP, Tunisia Holding…
He joined CarthaGenetics as a financial assistant, currently supporting the financial team to coordinate between companies (Switzerland, Germany, Tunisia, Algeria, Turkey, Italy, France and Spain).
Mohamed Walid speaks Arabic, English and French and is based in Carthage, Tunisia.

Sabri Hammar


Legal Affairs Director

Lawyer, graduated in Business Law from Tunis University, Sabri was a teacher at INTES, Carthage University. He has been working for CarthaGenetics from the founding of the company back in 2004.
Sabri is based in Carthage, Tunisia.


Sabri Hammar


Group Finance Controller

Alain joined CarthaGenetics as Group Finance Controller. He brings with him a rich twelve years’ experience of Operational Finance Control gained from various industries,in French and European groups, ranging from public transportation and energy to recycling and regeneration of raw materials.
He is also involved in teaching finance to help university-level students and continuous education employees prepare for French Accounting Degrees.
Alain holds a Master’s Degree in Business Administration and Logistics Management from Reims Management School, France.Alain is based in Paris, France.


Sabri Hammar


Executive Assistant

Insaf is Executive Assistant to the General Manager at CarthaGenetics. She holds a Master degree in English Language and Literature (linguistics). She worked as the Administrative Assistant at the African Development Bank (private and public sectors) before joining IBM Tunisia as the Administrative Assistant of the General Manager. Insaf speaks English, French and Arabic and is based in Carthage, Tunisia.

Sabri Hammar


Executive Assistant

Oğuz went to the Galatasaray High School in Istanbul and holds a diploma in Business Administration from Eylül University, the Faculty of Economics and Administrative Sciences, as well as an MA in Business English from Istanbul University.
Oğuz speaks Turkish, French and English, and is based in Izmir, Turkey.

Sabri Hammar


Information Technology Consultant

Görkem is a Chemist and a PhD Toxicologist. After working at Ankara University and University of Porto, as Research Assistant and as Assistant Professor, 10 years in total, he shifted to private sector related with academic information technology. He has been supporting CarthaGenetics and giving consultancy on information technology and pharma-chemical information since 2012.
Görkem is based in Ankara, Turkey.


Sabri Hammar


International Medical Director

Aroussi is graduated from the Tunis Faculty of Medicine, working with CarthaGenetics as International Medical Manager. He provides scientific guidance and support to the team, and shares medical information about our projects with doctors and health authorities on a regular basis.
Dr. Aroussi Bidani has established good relationships with both doctors and health authorities in Europe.
Aroussi is based in Düsseldorf, Germany.

Sabri Hammar


International Medical Manager

Amir is CarthaGenetics’ International Medical and Business Support Manager. He is a Medical Doctor with 6 years of medical practice in various settings, and 5 years’ experience in Market Access Consulting for the Pharmaceutical Industry. Amir’s research interests include Immunology, Internal Medicine and Oncology. His research works focus on antibodies’ diagnostic value in connective tissue diseases, as well as regulatory and economic requirements for the Market Access of Orphan and Innovative Therapeutics in the EU. Amir provides targeted methodology approaches for CarthaGenetics’ projects, as well as scientific communications to the CarthaGenetics team, to physicians and health authorities worldwide. Amir speaks English, French and Arabic, and is based in Carthage, Tunisia.

Sabri Hammar


International Medical Manager

Samira is graduated from the University of Medicine of Oran, Algeria, with a fellowship in pediatrics in Oran, in a private practice specialized in orphan diseases, neurology and metabolic diseases. Additionally, she worked as a gynecologic ward at the University Hospital in Oran and in a cardiology clinic, in pediatric plastic and reconstructive surgery at the Hôpital Robert Debré and urology surgery in Clinique Hôtel Dieu, both in Paris, France. Samira also worked as a research assistant on asthma in Latin-American population in Los Angeles, California. She speaks English, French, Spanish and Arabic.
Samira has dual citizenship Algerian/French and is based in Alicante, Spain.


guvenc Kockaya


International Market Access, Pricing & Reimbursement Director

Güvenç joined CarthaGenetics® in 2016 as International Market Access Director, also in charge of Pricing and Reimbursement.  He is a medical doctor and health economist, bringing to the team his triple experience of public, private and academic practice in the Market Access field, particularly applied to large-sized pharmaceuticals and biotechs. He holds a master in Pharmacoeconomics and Pharmacoepidemiology, and a doctorate in Clinical Pharmacology and Medical Pharmacology. He completed a European Market Access Diploma Program in France and studied as a fellow at Temple University’s Center for Pharmaceutical Health Services Research in US. He has had several articles published in journals or posters presented in congresses. He has also served as the Turkish translation editor of Bootman’s “Principles of Pharmacoeconomics” and WHO’s “Health Technology Assessment in Medical Devices”. He is the lead editor of “Pharmaceutical Market Access in Emerging Markets”. He worked for the Ministry of Health of Turkey as health economist and a member of reimbursement sub-committee, and for medical device and pharmaceutical companies as Market Access lead. Since 2017 Güvenç is Assistant Professor at Turkey’s Beykent University, Medical Faculty, Pharmacology Department. He is based in Ankara, Turkey.

Sabri Hammar


European Price & Reimbursement Manager

Haythem is a PharmD and holds an MSc from the EM Lyon Business School and a Master of Marketing from East China Normal University in Shanghai.
He worked in a consultancy project within the Institut Pasteur of Shanghai. Haythem is specialized in pricing, reimbursement and Market Access as he holds a postgraduate diploma of the European Market Access from Université Claude Bernard Lyon I. Besides, Haythem has experience in EAP in Europe and strong relationships with key stakeholders at hospital levels and Health Authorities in France, Malta and Croatia. He already participated in successful launch of orphan drugs in France, Malta and Croatia.
Haythem is based in Paris, France.

saber salem_B&W


Regulatory Affairs Consultant, Tunisia

Saber joined CarthaGenetics® in 2017 as Regulatory Affairs Consultant for Tunisia. He is a pharmacist with a specialization in Regulatory Affairs and Toxicology, bringing to the team over a decade of regulatory practice acquired at companies such as SIPHAT (Société des Industries Pharmaceutiques de Tunisie), Pfizer Tunisia and CEVA Santé Animale. His dual experience combines in-depth knowledge of the local Tunisian pharmaceutical market with broad expertise of corporate functions such as manufacturing & control, site management, quality assurance, supply chain and regulatory.  Saber is graduated from the Faculty of Pharmacy of Monastir. He holds a master’s degree in regulatory affairs and patenting of pharmaceutical & medical device products from the University of Ferrara, Italy and a master degree in toxicolgy from the  Faculty of Medicine of Sfax. He aslo completed a master’s degree in bsuiness & industrial management from the Virtual University of Tunis. Saber is based in Tunis, Tunisia.


Sabri Hammar


Regulatory Affairs Manager, Turkey

Burcu is graduated from the American College Institute, Izmir, and from the Faculty of Pharmacy from Hacettepe University. She has been running her own pharmaceutical warehouse company in Aydın for seven years. She also worked as a retail pharmacist for eleven years in İzmir. Burcu joined the CarthaGenetics team as Regulatory Affairs Manager and worked on orphan drugs projects in cardiology, endocrinology, neurology and nephrology. She is an expert on preparation of patient folders that will be examined by the Ministry of Health.
Burcu also participated in patient identification for clinical trials all over Turkey. She is also responsible for regulatory relations with the Ministry of Health, Social Security Association and all corporate affairs in Turkey.
Burcu is based in Izmir, Turkey.

Imane Belala


Regulatory Affairs Manager, Algeria

Imane joined the North Africa team of CarthaGenetics® in 2016. She brings on board a few years of experience of the Algerian regulatory affairs in the context of drug development and biosimilars. Graduated in Chemistry from the University of Medicine of Oran, Algeria, she first worked as an analytical chemist in quality control, involved across all key steps in the drug development process. Later, she worked as infection control specialist focusing on the prevention and control of infectious disease outbreaks in hospital settings in Algiers.
Imane speaks French and Arabic and is based in Algiers, Algeria.


Sabri Hammar


Country Director, Switzerland

Alain has been partnering with CarthaGenetics  for the Swiss market since 2015. Trained as a Pharmacist at the University of Lausanne (1993), Alain brings on board more than 20 years of sales, marketing and management experience, with specifically 10 years in Orphan Drugs. During his nearly 8 years with Shire, Alain ensured several roles, from Country Director Switzerland to General Manager, Switzerland & Benelux, with the respective Country Directors reporting to him. Alain was in charge of four marketed Orphan products, with three launched during this period. He provides CarthaGenetics customers with an in-depth knowledge of the Swiss market and its related OD highly specialized ecosystem.
Alain is based close to Montreux, Switzerland.

Sabri Hammar


Area Director Turkey

Erhan is the Country Director of CarthaGenetics® Turkey. She brings on board close to 20 years of experience in medical, sales and marketing departments of international pharmaceutical companies. After obtaining her BA in Chemistry from Boğaziçi University, she first worked for Boehringer Ingelheim and Schering Plough in medical and sales departments; and later joined the Orphan Diseases market as one of the first employees of Genzyme Turkey. She contributed a great deal to the establishment of the Orphan Diseases concept in an orphan disease-naïve Turkey. She later left Genzyme after the Sanofi acquisition, and joined CarthaGenetics®. Erhan speaks Turkish, English and Dutch, and is based in Istanbul, Turkey.



Sabri Hammar


Country Director, Italy

Riccardo has a long business career with top positions in Italian and multinational pharmaceutical companies in the hematological, endocrinology and pediatric fields. Specialist in Orphan Drugs to initiate Early Access Programs, according to the Italian legislation (Laws 326/03 and 648/96), Riccardo has also developed an expertise for market assessment, market development and patients finding.
Riccardo is based in Milano, Italy.

Sabri Hammar


Country Manager, Italy

Stéphane is a PharmD and holds an MS in Marketing Management from the ESSEC Business School, Paris. He is specialized in Pricing, Reimbursement and Market Access as he holds a postgraduate diploma of the Chairs ‘Health Economy’ and ‘Therapeutic Innovation’ from ESSEC Business School. After his experience in Pipeline Management at Roche, Stéphane joined CarthaGenetics and is now in charge of EAP in France and Italy, where he already participated in the successful launch of many orphan drugs. Stéphane speaks French, English and Italian and is based in Marseilles, France.


Sabri Hammar


International Account Manager, Turkey, Azerbaijan, Bulgaria

Filiz is a Medical Biologist (Istanbul University, Cerrahpasa Medical Faculty) who holds Masters in Genetics (Istanbul University, Institute for Experimental Medical Research,) and has a degree in Management of Health Institutions. She has expertise in clinical trials management (Phases 2-3), patient finding for orphan drugs and rare diseases, EAP (EndikasyonDışı process) in Turkey and feasibility studies for clinical trials in Bulgaria. She has worked in the nephrology, neurology, metabolic disorders, and cardiology and genetics areas.
Filiz has dual citizenship Bulgarian / Turkish and is based in Istanbul, Turkey.

Sabri Hammar


National Account Manager Turkey

Mustafa joined the CarthaGenetics team as a Pharmaceutical Consultant. He has a university degree from the Anadolu University School of Business Administration. He is an expert in quality management systems, consultancy in medical, pharmaceuticals and healthcare products.
His expertise in regulatory affairs, added to his capacity in establishing good inter-personal relationships, makes him a globally competent partner in the field of healthcare.
Mustafa is based in Ankara, Turkey.